318 / 1816
NTCP models using individual patient data of 2 large trials
Mukesh et al, 2013
•
Development of model using pooled data of: boost no boost trial &
Cambridge IMRT trial
•
Validated using the START-pilot trial
•
EQD2 for 50% risk on moderate/severe fibrosis:
about 80 Gy